Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Activity of mRNA COVID-19 vaccines in patients with lymphoid malignancies

13 Aug 2021

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to COVID-19 and healthcare impacts
Share to SARS-CoV-2 and COVID-19 Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34387646
DOI: 10.1182/bloodadvances.2021005328

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Activity of mRNA COVID-19 vaccines in patients with lymphoid malignanciesPMID 34387646Read ↗

From COVID-19 to Cancer mRNA Vaccines: Moving From Bench to Clinic in the Vaccine LandscapeSemantic proximity Read ↗

COVID-19 Vaccines: Bolstering Cancer TreatmentSemantic proximity Read ↗

Advancement insights in cancer vaccines: mechanisms, types, and clinical applicationsSemantic proximity Read ↗

mRNA-based therapeutics: looking beyond COVID-19 vaccinesSemantic proximity Read ↗

First COVID-19 DNA vaccine approved, others in hot pursuitSemantic proximity Read ↗

mRNA Vaccine Technology Beyond COVID-19Semantic proximity Read ↗

Impaired immune response to COVID-19 vaccination in patients with B-cell malignancies after CD19 CAR T-cell therapySemantic proximity Read ↗

The dawn of mRNA vaccines: The COVID-19 caseSemantic proximity Read ↗

Immunogenicity of SARS-CoV-2 messenger RNA vaccines in patients with cancerSemantic proximity Read ↗

mRNA cancer vaccines: Advances, trends and challengesSemantic proximity Read ↗

Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responsesSemantic proximity Read ↗

DNA vaccines join the fight against COVID-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.